Vmn1r143 Activators
Vomeronasal 1 receptor 143 activators are compounds that can enhance the receptor's signaling through the modulation of intracellular cAMP levels. Forskolin is a potent activator of adenylyl cyclase, which catalyzes the conversion of ATP to cAMP. An increase in cAMP levels can activate PKA, which then phosphorylates various proteins that can enhance the signaling of vomeronasal 1 receptor 143. This direct activation of the cAMP pathway suggests that forskolin can facilitate the receptor's function by bolstering the downstream signaling cascade necessary forits activation. Similarly, IBMX can lead to elevated cAMP levels through the inhibition of phosphodiesterases, thereby preventing the breakdown of cAMP and maintaining PKA activity at a level that supports vomeronasal 1 receptor 143 signaling.
The action of cholera toxin, which irreversibly activates Gs alpha proteins, results in a prolonged increase in cAMP levels that can continuously promote PKA signaling. This sustained signaling is beneficial for the functional activity of vomeronasal 1 receptor 143 as it relies on PKA for its activation and subsequent action. On the other hand, compounds like epinephrine, isoproterenol, dopamine, and histamine interact with their respective G-protein coupled receptors, leading to the activation of adenylyl cyclase and a subsequent rise in cAMP. This elevation in cAMP enhances the PKA signaling pathway, which indirectly supports the activity of vomeronasal 1 receptor 143. PACAP, by activating its receptors, also causes an increase in cAMP and thereby facilitates the receptor's activity through the same mechanism. Anandamide and adenosine, through their interaction with respective cannabinoid and adenosine A2 receptors, can similarly lead to increased cAMP levels, further enhancing the signaling pathway linked to vomeronasal 1 receptor 143. Lastly, rolipram inhibits PDE4, leading to increased cAMP levels and prolonged PKA signaling, which can enhance the functional activity of the receptor.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX acts as a non-specific inhibitor of phosphodiesterases, enzymes responsible for the breakdown of cAMP. By preventing cAMP degradation, IBMX can indirectly increase the activity of vomeronasal 1 receptor 143 since persistent cAMP can perpetuate PKA activity and downstream signaling related to the receptor function. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) functions as a ligand for its G-protein coupled receptors, which can trigger intracellular signaling cascades involving cAMP elevation. This subsequent rise in cAMP may indirectly enhance the functional activity of vomeronasal 1 receptor 143 by sustaining PKA-mediated signaling processes. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors which can result in the activation of adenylyl cyclase and an increase in cAMP. This elevation of cAMP can support the activity of vomeronasal 1 receptor 143 by enhancing PKA function and subsequent signal transduction processes intrinsic to the receptor. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can lead to the activation of adenylyl cyclase and a rise in cAMP levels. The increased cAMP can indirectly enhance vomeronasal 1 receptor 143 activity via the PKA signaling pathway. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can bind to its dopamine receptors, some of which can activate adenylyl cyclase and elevate cAMP levels. This boost in cAMP can then enhance the functional activity of vomeronasal 1 receptor 143 through PKA-mediated signaling. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, when bound to H2 receptors, can lead to the activation of adenylyl cyclase and increased cAMP. This cascade can indirectly enhance the activity of vomeronasal 1 receptor 143 by facilitating PKA-dependent signaling pathways. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine can activate adenosine A2 receptors, which positively couple to adenylyl cyclase, leading to increased cAMP. This increment in cAMP can enhance the signaling activity of vomeronasal 1 receptor 143 through the PKA pathway. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which breaks down cAMP. By inhibiting PDE4, rolipram can indirectly support the activity of vomeronasal 1 receptor 143 due to raised cAMP levels sustaining PKA signaling. | ||||||